Safety of Biologic and Small Molecule Therapy for Inflammatory Bowel Disease Among Solid Organ Transplant Recipients: Systematic Review and Meta-Analysis.

Vikas TanejaRajsavi S AnandMohammed El-DallalJeffrey DongNisa DesaiIsha TanejaJoseph D Feuerstein

Published in: Inflammatory bowel diseases (2023)

Biologic therapy is overall well tolerated in patients with solid organ transplant. Long-term studies are needed to better define the role of specific agents in this patient population.

Keyphrases

small molecule
rheumatoid arthritis
case report
protein protein
case control
bone marrow
cell therapy